Sub-Groups

• Biostatistics Service (5150)
• Computational Oncology Service (654)
• Epidemiology Service (1106)
• Health Outcomes Research Group (1161)

Types of Work

["2019"]

[[["Journal Articles",5062],["Meeting Abstracts",2359],["Editorials",59],["Reviews",40],["Conference Papers",38],["Correspondences",36],["Research Letters",33],["Book Sections",28],["Guidelines",10],["Miscellaneous",6],["Books Whole",2]]]

[7673]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• major clinical study
• male
• middle aged
• priority journal

Recent Works

1. Treatment response and clinical outcomes of well-differentiated (WD) high-grade (HG) neuroendocrine tumors (NETs) to (177)Lu-DOTATATE

   Meeting Abstract

   Coffman, K.; Bodei, L.; Le, T.; Choi, Y.; Chou, J.; Capanu, M.; Dunphy, M.; Fox, J.; Grewal, R.; Reddy, R.; more...
   Pancreas (2022)

   Fulltext@MSK | Save
2. Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well- differentiated neuroendocrine tumors (WDNETs)

   Meeting Abstract

   Raj, N.; Cruz, E.; Chou, J.; Capanu, M.; DeMore, A.; Hauser, H.; Heffernan, O.; Le, T.; Saltz, L.; Reidy-Lagunes, D.
   Pancreas (2022)

   Fulltext@MSK | Save
3. Treatment response and clinical outcomes of neuroendocrine neoplasms (NENs) treated with immune checkpoint inhibitors (ICIs): A single institution experience

   Meeting Abstract

   Hauser, H.; Le, T.; Chou, J. F.; Heffernan, O.; DeMore, A.; Gonen, S.; Capanu, M.; Reidy-Lagunes, D.; Raj, N.
   Pancreas (2022)

   Fulltext@MSK | Save